Aprogen Biologics Inc. (KRX:003060)
South Korea
· Delayed Price · Currency is KRW 251.00
+12.00 (5.02%)
Apr 14, 2026, 7:45 AM KST
Aprogen Biologics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -170,331 | -104,979 | -118,270 | 12,639 | 8,103 | Upgrade
|
| Depreciation & Amortization | 19,185 | 19,090 | 21,398 | 2,404 | 2,072 | Upgrade
|
| Loss (Gain) From Sale of Assets | -88.69 | -16.15 | 151,537 | -3.1 | -53.08 | Upgrade
|
| Asset Writedown & Restructuring Costs | 637.76 | 154.08 | 2,271 | 264.15 | 2,134 | Upgrade
|
| Loss (Gain) From Sale of Investments | 9,616 | 9,934 | -34,724 | -1,380 | -1,623 | Upgrade
|
| Loss (Gain) on Equity Investments | 77,377 | 29,047 | -75,012 | -1,353 | -352.2 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.49 | 0.01 | -24.29 | -2,224 | -26.23 | Upgrade
|
| Other Operating Activities | 28,250 | 16,980 | 31,164 | 1,476 | -720.21 | Upgrade
|
| Change in Accounts Receivable | 3,021 | -2,217 | 1,218 | -637.92 | -494.75 | Upgrade
|
| Change in Inventory | -149.22 | -5,708 | -3,284 | -1,180 | -1,023 | Upgrade
|
| Change in Accounts Payable | -613.74 | 662.83 | -2,373 | 313.46 | -155.63 | Upgrade
|
| Change in Other Net Operating Assets | -5,136 | 6,056 | -7,550 | 15,410 | -14,088 | Upgrade
|
| Operating Cash Flow | -38,233 | -30,996 | -33,651 | 25,728 | -6,227 | Upgrade
|
| Capital Expenditures | -9,625 | -15,264 | -28,088 | -1,284 | -796.19 | Upgrade
|
| Sale of Property, Plant & Equipment | 210.7 | 16.53 | 16.82 | 16.36 | 66.71 | Upgrade
|
| Cash Acquisitions | -5,080 | - | -9,223 | - | - | Upgrade
|
| Divestitures | 2,622 | 200 | - | 3,074 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -154.86 | -187.34 | -308.06 | -261.4 | -145.94 | Upgrade
|
| Investment in Securities | -880.82 | -12,262 | -79,690 | 22,197 | 75,048 | Upgrade
|
| Other Investing Activities | -72,212 | -24,225 | 22,086 | -76,742 | -97,329 | Upgrade
|
| Investing Cash Flow | -85,119 | -51,722 | -95,206 | -53,001 | -23,156 | Upgrade
|
| Short-Term Debt Issued | 41,800 | 53,950 | 49,610 | 20,500 | - | Upgrade
|
| Long-Term Debt Issued | 97,972 | 39,997 | 114,611 | - | - | Upgrade
|
| Total Debt Issued | 139,772 | 93,947 | 164,221 | 20,500 | - | Upgrade
|
| Short-Term Debt Repaid | -3,000 | -60,650 | -122,110 | -4,000 | - | Upgrade
|
| Long-Term Debt Repaid | -1,635 | -61,594 | -353.06 | -262.55 | -349.3 | Upgrade
|
| Total Debt Repaid | -4,635 | -122,244 | -122,463 | -4,263 | -349.3 | Upgrade
|
| Net Debt Issued (Repaid) | 135,136 | -28,297 | 41,758 | 16,237 | -349.3 | Upgrade
|
| Issuance of Common Stock | 0.61 | 115,759 | 40,000 | 0.24 | - | Upgrade
|
| Repurchase of Common Stock | - | -21.72 | -4,425 | - | - | Upgrade
|
| Other Financing Activities | -0.08 | -2,468 | 37,957 | -455.34 | -0.96 | Upgrade
|
| Financing Cash Flow | 135,137 | 84,972 | 115,289 | 15,782 | -350.26 | Upgrade
|
| Foreign Exchange Rate Adjustments | 301.4 | - | 11.65 | 25.04 | 11.02 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | 0 | -0 | Upgrade
|
| Net Cash Flow | 12,086 | 2,253 | -13,555 | -11,465 | -29,722 | Upgrade
|
| Free Cash Flow | -47,857 | -46,261 | -61,739 | 24,444 | -7,023 | Upgrade
|
| Free Cash Flow Margin | -65.36% | -68.66% | -70.67% | 37.50% | -12.43% | Upgrade
|
| Free Cash Flow Per Share | -3632.91 | -5519.38 | -14680.21 | 9071.14 | -2642.97 | Upgrade
|
| Cash Interest Paid | 4,930 | 2,213 | 151.04 | 25.77 | 89.51 | Upgrade
|
| Cash Income Tax Paid | 1,736 | -31.26 | -2,485 | 2,115 | 1,810 | Upgrade
|
| Levered Free Cash Flow | -82,778 | -24,026 | 13,979 | 104,474 | -97,245 | Upgrade
|
| Unlevered Free Cash Flow | -76,091 | -20,579 | 16,272 | 104,645 | -97,226 | Upgrade
|
| Change in Working Capital | -2,878 | -1,207 | -11,990 | 13,906 | -15,761 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.